000 01618 a2200457 4500
005 20250513061427.0
264 0 _c19931004
008 199310s 0 0 eng d
022 _a0105-4538
024 7 _a10.1111/j.1398-9995.1993.tb02410.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPedersen, B
245 0 0 _aThe effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X.
_h[electronic resource]
260 _bAllergy
_cJul 1993
300 _a377-82 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAdrenergic beta-Agonists
_xpharmacology
650 0 4 _aAdult
650 0 4 _aAlbuterol
_xanalogs & derivatives
650 0 4 _aAllergens
650 0 4 _aAsthma
_xblood
650 0 4 _aBlood Proteins
_xanalysis
650 0 4 _aBronchial Provocation Tests
650 0 4 _aDouble-Blind Method
650 0 4 _aEosinophil Granule Proteins
650 0 4 _aEosinophil-Derived Neurotoxin
650 0 4 _aEosinophils
650 0 4 _aFemale
650 0 4 _aForced Expiratory Volume
650 0 4 _aHistamine
650 0 4 _aHumans
650 0 4 _aLeukocyte Count
650 0 4 _aMale
650 0 4 _aRibonucleases
650 0 4 _aSalmeterol Xinafoate
700 1 _aDahl, R
700 1 _aLarsen, B B
700 1 _aVenge, P
773 0 _tAllergy
_gvol. 48
_gno. 5
_gp. 377-82
856 4 0 _uhttps://doi.org/10.1111/j.1398-9995.1993.tb02410.x
_zAvailable from publisher's website
999 _c8102969
_d8102969